MedPath
HSA Approval

MEDRINATE SYRUP 25 mg/5 ml

SIN07645P

MEDRINATE SYRUP 25 mg/5 ml

MEDRINATE SYRUP 25 mg/5 ml

January 10, 1994

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

A04AD

其它镇吐药

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

DIMENHYDRINATE

25 mg/5 ml

Dimenhydrinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MEDRINATE SYRUP 25 mg/5 ml - HSA Approval | MedPath